ResearcherHarvard UniversityActive in the last 2 years
Jonathan P. Celli
Matched on ORCID iD 0000-0003-3560-0770; OpenAlex author ID A5107115177; NIH RePORTER profile ID 10294019. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 6)
- Trials
- 0
- Grants
- 2
- Labs led
- 1
- Collaborators
- 9
2011: 1 paper · 2012: 1 grant · 2013: none · 2014: none · 2015: 1 grant · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 2 papers
Papers 8
- Efficacy of photodynamic therapy using 5-aminolevulinic acid-induced photosensitization is enhanced in pancreatic cancer cells with acquired drug resistance. Last author DOI 10.1016/j.pdpdt.2024.104362↗
- Drug resistant pancreatic cancer cells exhibit altered biophysical interactions with stromal fibroblasts in imaging studies of 3D co-culture models. Last author DOI 10.1038/s41598-024-71372-9↗
- Photodynamic Stromal Depletion Enhances Therapeutic Nanoparticle Delivery in 3D Pancreatic Ductal Adenocarcinoma Tumor Models. Last author DOI 10.1111/php.13663↗
- Photodestruction of Stromal Fibroblasts Enhances Tumor Response to PDT in 3D Pancreatic Cancer Coculture Models. Last author DOI 10.1111/php.13339↗
- Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers13174354↗
- Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids. Co-author DOI 10.18632/oncotarget.24425↗
- ECM Composition and Rheology Regulate Growth, Motility, and Response to Photodynamic Therapy in 3D Models of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1158/1541-7786.mcr-16-0260↗
- Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines. Co-author DOI 10.1002/lsm.21093↗
Grants 2
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Vida Karimnia · 4 shared papers, 2021–2024 · strength 0.85
- Paper Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers13174354↗
- Paper Photodynamic Stromal Depletion Enhances Therapeutic Nanoparticle Delivery in 3D Pancreatic Ductal Adenocarcinoma Tumor … DOI 10.1111/php.13663↗
- Paper Drug resistant pancreatic cancer cells exhibit altered biophysical interactions with stromal fibroblasts in imaging stu… DOI 10.1038/s41598-024-71372-9↗
- Frank J. Slack · 4 shared papers, 2021–2024 · strength 0.85
- Paper Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers13174354↗
- Paper Photodynamic Stromal Depletion Enhances Therapeutic Nanoparticle Delivery in 3D Pancreatic Ductal Adenocarcinoma Tumor … DOI 10.1111/php.13663↗
- Paper Drug resistant pancreatic cancer cells exhibit altered biophysical interactions with stromal fibroblasts in imaging stu… DOI 10.1038/s41598-024-71372-9↗
- Tayyaba Hasan · 3 shared papers, 2011–2024 · strength 0.38
- Paper Efficacy of photodynamic therapy using 5-aminolevulinic acid-induced photosensitization is enhanced in pancreatic cance… DOI 10.1016/j.pdpdt.2024.104362↗
- Paper Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer … DOI 10.18632/oncotarget.24425↗
- Paper Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines. DOI 10.1002/lsm.21093↗
- Gwendolyn M. Cramer · 2 shared papers, 2017–2024 · strength 0.32
- Paper Drug resistant pancreatic cancer cells exhibit altered biophysical interactions with stromal fibroblasts in imaging stu… DOI 10.1038/s41598-024-71372-9↗
- Paper ECM Composition and Rheology Regulate Growth, Motility, and Response to Photodynamic Therapy in 3D Models of Pancreatic… DOI 10.1158/1541-7786.mcr-16-0260↗
- Yiran Liu · 1 shared paper, 2024 · strength 0.26
- Eric Struth · 1 shared paper, 2024 · strength 0.22
- Anne‐Laure Bulin · 1 shared paper, 2018 · strength 0.09
- Mans Broekgaarden · 1 shared paper, 2018 · strength 0.09
- Stephen P. Pereira · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.